Results 191 to 200 of about 1,776,183 (353)
Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors [PDF]
Stéphane Raeppel +7 more
openalex +1 more source
The chronic glutamate‐induced excitotoxicity hypothesis has profoundly informed the therapeutic strategies employed in Alzheimer’s disease (AD). This study shows pigment epithelium‐derived factor (PEDF) regulates astrocytic glutamate transporter‐1 (GLT‐1)‐mediated glutamate homeostasis and cognition. Reduced PEDF correlates with lower Mini‐Mental State
Jin‐Hui Shi +15 more
wiley +1 more source
Comparison of the Use of Immune Checkpoint Inhibitor/Tyrosine Kinase Inhibitor and Tyrosine Kinase Inhibitor Alone for Patients With Low Risk Metastatic Renal Cell Carcinoma. [PDF]
Oki M +8 more
europepmc +1 more source
INCIDENCE OF HEPATITIS B REACTIVATION DURING EGFR TYROSINE KINASE INHIBITORS TREATMENT IN NON‐SMALL‐CELL LUNG CANCER PATIENTS [PDF]
openalex +1 more source
Skin problems and EGFR-tyrosine kinase inhibitor.
T. Kozuki
semanticscholar +1 more source
This study reveals that circPVT1 promotes the renal cell carcinoma lung metastasis and tumor progression through encoding the cP104aa peptide and directly binds with EIF4A3, which jointly regulates the target gene c‐MYC. Abstract Circular RNA (circRNA) plays a pivotal role in the pathogenesis of renal cell carcinoma (RCC).
Houliang Zhang +10 more
wiley +1 more source
Analysis of the Role of the SRC Tyrosine Kinase and Podoplanin in the Process of Entosis. [PDF]
Gawel AM +3 more
europepmc +1 more source
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.
J. Woyach +24 more
semanticscholar +1 more source

